date,title,source
Oct-17-18,"As opioid crisis raged, Insys pushed higher doses of addictive drug and pushed salespeople to own doctors",MarketWatch
Oct-18-18,Up and Coming Cannabis Company on a Roll,ACCESSWIRE
Oct-18-18,"As opioid crisis raged, Insys pushed higher doses of addictive drug and pushed salespeople to own doctors",MarketWatch
Oct-19-18,"As opioid crisis raged, Insys pushed higher doses of addictive drug and pushed salespeople to own doctors",MarketWatch
Oct-22-18,INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5,GlobeNewswire
Oct-29-18,"Consolidated Research: 2018 Summary Expectations for Insys Therapeutics, Achaogen, Astec Industries, Central European Media Enterprises, Pzena Investment Management, and Clementia Pharmaceuticals  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Oct-30-18,What's in Store for INSYS Therapeutics' (INSY) Q3 Earnings?,Zacks
Nov-01-18,Oversold CBD Stocks,ACCESSWIRE
Nov-01-18,INSYS Therapeutics Announces Results of PK Study Assessing Proprietary Intranasal Naloxone Formulations versus Intramuscular and Intravenous Naloxone for Opioid Overdose,GlobeNewswire
Nov-05-18,"Insys Therapeutics (INSY) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-05-18,Insys Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-05-18,INSYS Therapeutics Reports Third Quarter 2018 Results,GlobeNewswire
Nov-05-18,INSYS Therapeutics to Assess Strategic Alternatives for Opioid-Related Assets,GlobeNewswire
